Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Generation of Bioengineered Vascularized Liver Tissue from Human Pluripotent Stem Cells

FY 2023-24

Summary
Chronic liver disease (CLD) affects many Canadians, often leading to end-stage liver failure. Although transplantation remains the primary treatment, the scarcity of donor organs necessitates alternative therapies. Liver fibrosis, a critical stage in CLD, involves various cells beyond hepatocytes which existing in vitro models fail to include and fall short in replicating the native liver's complexity. Human pluripotent stem cells (hPSCs) show promise for treating liver failure. Our lab has developed protocols to generate mature hepatocytes, HSCs, and endothelial cells from hPSCs. Integrating our hPSC-derived cells with advanced micro-fabrication techniques aims to enhance hepatic function by replicating the liver's microenvironment. This model serves as a vital platform to explore new therapeutic strategies. Our investigation includes developing a vascularized hPSC-derived Liver-on-Chip Model and a Human Liver Fibrosis hPSC-derived Liver-on-Chip Model. These initiatives aim to illuminate cellular interactions promoting sustained hPSC-hepatocyte engraftment in vivo and establish drug screening and metabolism platforms. This research will advance stem-cell-based therapies for CLD, potentially transforming patient care and treatment options
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506418
Name
Kondo Manami
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Generation of Bioengineered Vascularized Liver Tissue from Human Pluripotent Stem Cells
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chronic Liver Disease; Hepatic Stellate Cells; Human Pluripotent Stem Cell; Liver Fibrosis Modeling; Microenvironment; Non-Parenchymal Cells; Organ-On-Chip; Stem Cell Biology; Tissue Regeneration; Vascular Network
Abstract
Chronic liver disease (CLD) affects many Canadians, often leading to end-stage liver failure. Although transplantation remains the primary treatment, the scarcity of donor organs necessitates alternative therapies. Liver fibrosis, a critical stage in CLD, involves various cells beyond hepatocytes which existing in vitro models fail to include and fall short in replicating the native liver's complexity. Human pluripotent stem cells (hPSCs) show promise for treating liver failure. Our lab has developed protocols to generate mature hepatocytes, HSCs, and endothelial cells from hPSCs. Integrating our hPSC-derived cells with advanced micro-fabrication techniques aims to enhance hepatic function by replicating the liver's microenvironment. This model serves as a vital platform to explore new therapeutic strategies. Our investigation includes developing a vascularized hPSC-derived Liver-on-Chip Model and a Human Liver Fibrosis hPSC-derived Liver-on-Chip Model. These initiatives aim to illuminate cellular interactions promoting sustained hPSC-hepatocyte engraftment in vivo and establish drug screening and metabolism platforms. This research will advance stem-cell-based therapies for CLD, potentially transforming patient care and treatment options
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kondo, Manami
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~